Anika Therapeutics: B. Riley cuts target price to $17 from $23
ANIK•B. Riley cut its target price for Anika Therapeutics to $17 from $23.
Related News

Strive buys 251 bitcoin at average price of $69,853 each
ASST•

ALX Oncology Q3 net loss per share narrows
ALXO•

Eurofins corrects date of François Vigneau’s share sale to Oct. 23, 2026
EURN•

Pluri expects 50% stake in ZEO ScientifiX under strategic agreement
PLUR•

Veritone's Q3 revenue falls 30% on VDR product decline
VERI•